Log in
Enquire now
VerImmune

VerImmune

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Joshua Weiyuan Wang
0
CIK Number
1,903,915
Crunchbase URL
crunchbase.com/organiz...erimmune
Email Address
info@verimmune.com
Facebook URL
@VerImmune
Founded Date
2020
Full Address
1812 ASHLAND AVENUE SUITE 100 BALTIMORE, MD 21205
Industry
Biotechnology
Biotechnology
Health technology
Health technology
Investors
Ulu Ventures
Ulu Ventures
0
Gaingels
Gaingels
Mana Ventures
Mana Ventures
Proxima Ventures
Proxima Ventures
Latest Funding Round Date
September 23, 2024
Latest Funding Round Amount (USD)
4,500,000
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/verimmune
Location
United States
United States
Baltimore
Baltimore
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
1
Phone Number
+14434498836
Pitchbook URL
pitchbook.com/profiles...466441-48
Total Funding Amount (USD)
7,000,000
Twitter URL
@VerImmune_
Official Website
verimmune.com

Find more companies like VerImmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.